Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,24796327,half-maximal inhibitory concentration (IC50),"The half-maximal inhibitory concentration (IC50) of diclofenac, bromfenac, and amfenac was 55.5, 5.56, and 15.3 nM for human COX-1, and 30.7, 7.45, and 20.4 nM for human COX-2, respectively.",Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits. ,IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24796327/),nM,55.5,196771,DB06802,Nepafenac
,24796327,half-maximal inhibitory concentration (IC50),"The half-maximal inhibitory concentration (IC50) of diclofenac, bromfenac, and amfenac was 55.5, 5.56, and 15.3 nM for human COX-1, and 30.7, 7.45, and 20.4 nM for human COX-2, respectively.",Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits. ,IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24796327/),nM,5.56,196772,DB06802,Nepafenac
,24796327,half-maximal inhibitory concentration (IC50),"The half-maximal inhibitory concentration (IC50) of diclofenac, bromfenac, and amfenac was 55.5, 5.56, and 15.3 nM for human COX-1, and 30.7, 7.45, and 20.4 nM for human COX-2, respectively.",Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits. ,IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24796327/),nM,15.3,196773,DB06802,Nepafenac
,24796327,half-maximal inhibitory concentration (IC50),"The half-maximal inhibitory concentration (IC50) of diclofenac, bromfenac, and amfenac was 55.5, 5.56, and 15.3 nM for human COX-1, and 30.7, 7.45, and 20.4 nM for human COX-2, respectively.",Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits. ,IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24796327/),nM,30.7,196774,DB06802,Nepafenac
,24796327,half-maximal inhibitory concentration (IC50),"The half-maximal inhibitory concentration (IC50) of diclofenac, bromfenac, and amfenac was 55.5, 5.56, and 15.3 nM for human COX-1, and 30.7, 7.45, and 20.4 nM for human COX-2, respectively.",Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits. ,IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24796327/),nM,7.45,196775,DB06802,Nepafenac
,24796327,half-maximal inhibitory concentration (IC50),"The half-maximal inhibitory concentration (IC50) of diclofenac, bromfenac, and amfenac was 55.5, 5.56, and 15.3 nM for human COX-1, and 30.7, 7.45, and 20.4 nM for human COX-2, respectively.",Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits. ,IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24796327/),nM,20.4,196776,DB06802,Nepafenac
